LAUREN AYALA: Open Payments
NPI 1982871109 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,500 in 54 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $640 · 2025 $1,500
Food & beverage: $1,500
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $401 |
| Lundbeck LLC | 3 | $215 |
| CVRx, Inc. | 4 | $143 |
| UCB, Inc. | 4 | $137 |
| PFIZER INC. | 4 | $86 |
| Neurocrine BioSciences, Inc. | 2 | $76 |
| Kestra Medical Technology Services, Inc. | 3 | $67 |
| United Therapeutics Corporation | 2 | $66 |
| ARGENX US, INC. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
Products named: QULIPTA, VYEPTI, Barostim Neo System, INGREZZA, Assure WCD, Remodulin, Nayzilam, BOTOX.
Industry payments across GA — which companies pay providers there.
